Cargando…
IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial
Background: Cardiovascular comorbidities such as hypertension and inflammatory response dysregulation are associated with worse COVID-19 prognoses. Different cytokines have been proposed to play vital pathophysiological roles in COVID-19 progression, but appropriate prognostic biomarkers remain lack...
Autores principales: | Moll-Bernardes, Renata, de Sousa, Andrea Silvestre, Macedo, Ariane V. S., Lopes, Renato D., Vera, Narendra, Maia, Luciana C. R., Feldman, André, Arruda, Guilherme D. A. S., Castro, Mauro J. C., Pimentel-Coelho, Pedro M., de Albuquerque, Denílson C., de Paula, Thiago Ceccatto, Furquim, Thyago A. B., Loures, Vitor A., Giusti, Karla G. D., de Oliveira, Nathália M., De Luca, Fábio A., Kotsugai, Marisol D. M., Domiciano, Rafael A. M., Santos, Mayara Fraga, de Souza, Olga Ferreira, Bozza, Fernando A., Luiz, Ronir Raggio, Medei, Emiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353079/ https://www.ncbi.nlm.nih.gov/pubmed/34386533 http://dx.doi.org/10.3389/fcvm.2021.702507 |
Ejemplares similares
-
NKG2A Expression among CD8 Cells Is Associated with COVID-19 Progression in Hypertensive Patients: Insights from the BRACE CORONA Randomized Trial
por: Moll-Bernardes, Renata, et al.
Publicado: (2022) -
Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial
por: Macedo, Ariane Vieira Scarlatelli, et al.
Publicado: (2022) -
Troponin in COVID-19: To Measure or Not to Measure? Insights from a Prospective Cohort Study
por: Moll-Bernardes, Renata, et al.
Publicado: (2022) -
Influence of IL10 (rs1800896) Polymorphism and TNF-α, IL-10, IL-17A, and IL-17F Serum Levels in Ankylosing Spondylitis
por: Braga, Matheus, et al.
Publicado: (2021) -
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial
por: Lopes, Renato D., et al.
Publicado: (2020)